Wrapmanager Inc. Acquires New Position in Haleon plc (NYSE:HLN)

Wrapmanager Inc. bought a new position in Haleon plc (NYSE:HLN) in the fourth quarter, Holdings Channel reports. The institutional investor bought 11,781 shares of the company’s stock, valued at approximately $112,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Procyon Advisors LLC lifted its holdings in shares of Haleon by 41.3% in the 4th quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock worth $2,196,000 after acquiring an additional 67,329 shares during the last quarter. HighTower Advisors LLC grew its holdings in shares of Haleon by 27.2% during the 3rd quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after purchasing an additional 74,970 shares during the last quarter. Jane Street Group LLC raised its position in Haleon by 1,689.4% in the 3rd quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock worth $2,803,000 after purchasing an additional 250,169 shares during the period. Chartwell Investment Partners LLC lifted its stake in Haleon by 107.8% in the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock worth $5,030,000 after purchasing an additional 246,594 shares during the last quarter. Finally, Townsquare Capital LLC boosted its position in Haleon by 29.8% during the third quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock valued at $5,032,000 after buying an additional 109,217 shares during the period. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Price Performance

Shares of Haleon stock opened at $10.16 on Wednesday. The company’s fifty day simple moving average is $9.57 and its two-hundred day simple moving average is $9.83. Haleon plc has a 12-month low of $7.89 and a 12-month high of $10.80. The firm has a market cap of $45.97 billion, a PE ratio of 29.87, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on HLN. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.